Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 SubvariantsPanke Qu, Shan‐Lu Liu, Julia N. Faraone et al.|New England Journal of Medicine|2022Cited by 181
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2John P. Evans, Shan‐Lu Liu, Cong Zeng et al.|Cell Host & Microbe|2022Cited by 153
Transgenic swine: Expression of human CD39 protects against myocardial injuryDebra G. Wheeler, Richard J. Gumina, Matthew Joseph et al.|Journal of Molecular and Cellular Cardiology|2012Cited by 111
Neutralization and Stability of SARS-CoV-2 Omicron VariantCong Zeng, Shan‐Lu Liu, John P. Evans et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 104
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapyJason D. Roberts, Peter J. Mohler|Journal of Clinical Investigation|2019Cited by 57